Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients With Giant Cell Arteritis

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s228400
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Costs Associated With Adverse Events Among Acute Patients

BMC Health Services Research
Health Policy
2017English

THU0340 Adrenal Insufficiency During Glucocorticoid Treatment in Patients With Polymyalgia Reumatica or Giant Cell Arteritis

2017English

Hospital Costs Associated With Adverse Events in Gynecological Oncology

Gynecologic Oncology
GynecologyOncologyObstetrics
2011English

Giant Cell Arteritis.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

Practical Management of Adverse Events Associated With Cabozantinib Treatment in Patients With Renal-Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

126. Development and Validation of Case-Finding Algorithms for the Identification of Patients With Giant Cell Arteritis and Takayasu’s Arteritis in Large Healthcare Administrative Databases

Rheumatology
RheumatologyPharmacology
2019English

Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Internuclear Ophthalmoplegia in Giant Cell Arteritis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1992English

Vision‐Related and Health‐Related Quality of Life in Patients With Giant Cell Arteritis

Acta Ophthalmologica
MedicineOphthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy